Baicalin also demonstrates dual effectiveness: in H1299 lung cancer cells, it induces Akt-dependent apoptosis by suppressing the Akt/mTOR pathway [143], while in HT-29 colon cancer cells, it triggers apoptosis by inhibiting c-Myc and oncomiRNAs [144]. This evidence concerns the gene AKT1 and malignant colon neoplasm.